Ulrich G. Traugott
Plus aucun poste en cours
Historique de carrière de Ulrich G. Traugott
Anciens postes connus de Ulrich G. Traugott
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Knoll Pharmaceutical Co. | Corporate Officer/Principal | - | - |
| Glaxo Wellcome, Inc. | Directeur Technique/Scientifique/R&D | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | - | - |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Directeur Technique/Scientifique/R&D | 01/01/2006 | - |
Formation de Ulrich G. Traugott
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Allemagne | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Knoll Pharmaceutical Co. |
- Bourse
- Insiders
- Ulrich G. Traugott
- Expérience
